ArticlePDF Available

Significant Association of Candidate Genes (AGTR1 and TGF-Β1) Polymorphism with Diabetic Nephropathy in Diabetes Mellitus Type 2 Patients

Authors:

Abstract and Figures

Background/Aims: Diabetic nephropathy (DN) is one of the complications of diabetes mellitus (DM). This study aimed to investigate the association between genetic polymorphisms, specifically AGTR1 (rs5186) and TGF-β1 (rs1800470), and the risk of developing Diabetic nephropathy (DN) in type 2 diabetes mellitus patients, compared to those without DN and healthy controls. Methods: A case-control study was conducted on 165 diabetic patients (59 with diabetic nephropathy (DN) and 54 without DN (DM)), and 52 healthy controls (HC). The genotyping was done using amplification refractory mutation system method (ARMS-PCR). Age, gender, and duration of diabetes were matched across groups. Clinical parameters including FBS, RBS, HbA1C, creatinine, urea, SBP, DBP, total cholesterol, triglycerides, LDL, and BMI were assessed. Results: Diabetic patients with nephropathy exhibited significantly higher levels of clinical parameters compared to those without nephropathy and healthy controls. The risk allele of AGTR1, C (p <0.0001), and risk allele containing genotypes AC (p <0.0001) and CC (p-0.0010) were significantly higher in DN patients compared to DM and HC groups. Similarly, the TGF-β1 risk allele C (p-0.0001), and corresponding genotypes TC (p-0.0038) and CC (p-0.0027) were significantly associated with increased risk of diabetic nephropathy compared to DM and HC groups. Conclusion: The data showed significant association of AGTR1 (rs5186) and TGF-β1 (rs1800470) polymorphism with an increased risk of diabetic nephropathy in type 2 diabetes mellitus patients. More investigation will be required to disseminate the results, while increasing the samples size and using whole genome sequencing.
Content may be subject to copyright.
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 203
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
Original Paper
Accepted: 14 April 2024
This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). This means
that any user shall be free to copy and redistribute the material in any medium or format, also for commercial
purposes, provided proper credit is given to the Authors as well as the original publisher.
DOI: 10.33594/000000702
Published online: 6 May 2024
© 2024 The Author(s)
Published by Cell Physiol Biochem
Press GmbH&Co. KG, Duesseldorf
www.cellphysiolbiochem.com
© 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Signicant Association of Candidate Genes
(AGTR1 and TGF-Β1) Polymorphism with
Diabetic Nephropathy in Diabetes Mellitus
Type 2 Patients
Madeeha Ihsana Najeeb Ullah Khana Noreen Asima Muhammad Ismailb
Mikhlid H. Almutairic Ijaz Alid Brian D. Adamse
aInstitute of Biotechnology & Genetic Engineering (Health Division), The University of Agriculture
Peshawar, Pakistan, bDepartment of Zoology, Islamia College Peshawar, cZoology Department, College
of Science, King Saud University, P.O. Box: 2455, 11451, Riyadh, Saudi Arabia, dCentre for Applied
Mathematics and Bioinformatics (CAMB), Gulf University for Science and Technology, Hawally, Kuwait,
eDepartment of RNA Sciences, The Brain Institute of America, New Haven, CT, USA
Key Words
Type 2 diabetes mellitus • Diabetic nephropathy • AGTR1 • TGF-β1 • Gene polymorphism
Abstract
Background/Aims: Diabetic nephropathy (DN) is one of the complications of diabetes
mellitus (DM). This study aimed to investigate the association between genetic polymorphisms,
specically AGTR1 (rs5186) and TGF-β1 (rs1800470), and the risk of developing Diabetic
nephropathy (DN) in type 2 diabetes mellitus patients, compared to those without DN and
healthy controls. Methods: A case-control study was conducted on 165 diabetic patients (59
with diabetic nephropathy (DN) and 54 without DN (DM)), and 52 healthy controls (HC). The
genotyping was done using amplication refractory mutation system method (ARMS-PCR).
Age, gender, and duration of diabetes were matched across groups. Clinical parameters
including FBS, RBS, HbA1C, creatinine, urea, SBP, DBP, total cholesterol, triglycerides, LDL, and
BMI were assessed. Results: Diabetic patients with nephropathy exhibited signicantly higher
levels of clinical parameters compared to those without nephropathy and healthy controls. The
risk allele of AGTR1, C (p <0.0001), and risk allele containing genotypes AC (p <0.0001) and CC
(p- 0.0010) were signicantly higher in DN patients compared to DM and HC groups. Similarly,
the TGF-β1 risk allele C (p- 0.0001), and corresponding genotypes TC (p- 0.0038) and CC (p-
0.0027) were signicantly associated with increased risk of diabetic nephropathy compared to
DM and HC groups. Conclusion: The data showed signicant association of AGTR1 (rs5186)
and TGF-β1 (rs1800470) polymorphism with an increased risk of diabetic nephropathy in type
2 diabetes mellitus patients. More investigation will be required to disseminate the results,
while increasing the samples size and using whole genome sequencing.
Dr. Najeeb Ullah Khan Institute of Biotechnology and Genetic Engineering (Health Division),
The University of Agriculture Peshawar, PO, 25130, Pakistan.
Tel.: 00923339732955, E-Mail najeebkhan@aup.eu.pk
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 204
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
Introduction
Diabetes mellitus (DM) is a complex disorder, which is very common and rapidly growing
all over the world [1]. In 2002, about 173 million cases of DM were estimated worldwide
and this number was predicted to increase by 350 million in 2030 [2]. The disease is

of the microvascular complications of DM. It is estimated that approximately 30–40% of all



hyperlipidemia, hypertension, advanced glycation products accumulation, duration of


Transforming growth factor beta () belongs to a group of multifunctional growth
factors which control various biological processes such as apoptosis, senescence, healing
of wounds, tumor metastasis and suppression, cell division, differentiation and immunity
[6]. In humans, there are three isoforms of  namely ,  and .
Among these the  is the most abundant and is highly conserved in primary sequence
 controls the production and degradation of the renal


glucose in blood activates 
and the recombinant 
in cell hypertrophy [9]. The human  gene is located on chromosome 19q13.1–13.3
             
        
codons 10 and 25 are reported to be associated with increased or decreased levels of 
production   [11]. This increase or decrease in the production of  has been
 
 gene which affect its


) is found to be a highly

        

            
          



  
   
 gene is one of the potential
        


results. Understanding the clinical implications of these genetic variants is essential for
         
with type 2 diabetes mellitus. Therefore, our study aims to investigate the presence and
association of  and       

Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 205
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
Materials and Methods

This case control study was performed between February and December 2020 in the Institute of
   
     
  A written
informed consent was obtained from each participant after describing the aim of the study. T2DM was




years of diabetes duration with urinary albumin levels of  in at least two of three


     


 
protocol.

  
            


              
conditions for the  variant were; initial denaturation at 95°   
of denaturation at 95°°°
at 72°TGF
°

Table 1.


ͳ
ȋͳͳ͸͸Ȍ
ȋȌ
ͷǦǦ͵
ȋȌ
ͷǦǦ͵
ȋȌ
ͷǦǦ͵
ȋȌ
ͷǦǦ͵
Ǧβ1
ȋͺ͸ͻȌ

ͷǦǦ͵

ͷǦǦ͵

ͷǦǦ͵
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 206
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy

           
was used for demographic data analysis with 
    

            
             
ratio calculator. The 
Results


           
               
(<0.001), Urea (
blood pressure (<0.001), Diastolic blood pressure (<0.001), Total cholesterol (<0.001),
Triglycerides ( =0.023), and BMI
(             
    
among the study groups (Table 2).
Table 2.


high density lipids, BMI - Body mass index

ȋαͷͻȌ
ά
ȋαͷʹȌ
ά


ȋȌ
ͷ͹Ǥ͵άͷǤ͸Ͳ
ͷ͸Ǥ͹άʹǤͺͶ
ͲǤ͸ͺͻ
ȋȀȌ
ͺͺȀͺͻ
͹ͺȀ͹ͺ
ͲǤͻͷͻ
ȋȌ
ͳͳǤͶ͹άͳǤͲͳ͹
Ǧ
ͲǤͲͺ͸
ȋȀȌ
ͳͺͲǤͲάͶͲǤͻ
ͺ͹Ǥ͸άͺǤ͵Ͳ
δͲǤͲͲͳ
ȋȀȌ
ʹͳͻǤͲ͹ά͵ͷǤ͵
ͳʹͳǤ͹άͻǤͲʹ
δͲǤͲͲͳ
ͳȋΨȌ
ͺǤͳ͹άͳǤͲͳ
͵Ǥ͹͸άͲǤ͸͵
δͲǤͲͲͳ
ȋȀȌ
͸ǤͷͺάʹǤ͵ͳ
ͲǤͺͺάͲǤʹͲ
δͲǤͲͲͳ
ȋȀȌ
ͳͷ͵Ǥ͹ά͸͹Ǥʹ
ʹͲǤͳͲάͷǤʹͻ
δͲǤͲͲͳ
ȋȀȀͳǤ͹͵;Ȍ
ͻǤʹͶά͵Ǥ͹ͺ
ͻ͵Ǥͳάͳ͹Ǥͻ
δͲǤͲͲͳ
ȋȌ
ͳͶͳǤͶάͳͶǤͶ͹
ͳͳ͹ǤʹάͺǤͻͺ
δͲǤͲͲͳ
ȋȌ
ͻͲǤͻάͻǤͳʹ
ͺͲǤͺά͸ǤͶ͹
δͲǤͲͲͳ
ȋȀȌ
ͳͺ͵Ǥͺά͵ͺǤͻ͸
ͳͶͶǤͺ͹άͳͻǤͳͳ
δͲǤͲͲͳ
ȋȀȌ
ͳͶͺǤͻάͷʹǤ͹Ͳ
ͳͲͳǤʹͷάͳͶǤͳ͸
δͲǤͲͲͳ
ȋȀȌ
ͻͲǤͷ͵άʹͺǤͲʹ
͹͸Ǥʹ͹άͳ͵ǤͲʹ
ͲǤͲͲ͹
ȋȀȌ
͹͸ǤͲʹ
ͺͷǤͺͺάͳͷǤͲ͸
ͲǤͲͷͶ

͸͵ȋ͵ͷǤͷȌ
Ǧ
δͲǤͲͲͳ
ȋȀʹȌ
ʹͶǤ͵ͷάʹǤͺ͵
ʹͷǤͶͷάͲǤ͸͹
ͲǤͲͳͳ
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 207
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy


The allelic and genotypic frequencies of 
    
              
            
     =<0.0001,
=0.2055,


            
   
=0.2903) (Table 3).
Fig. 1.          
   
   
  

Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 208
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
Discussion
 is said to be an important regulator in the production and degradation of the


the renal hypertrophy could occur because of higher concentration of , such changes
 
          
   
activation, increased intraglomerular pressure and hypertension, which are said to induce
the production of 
 affect the
 is located
on the chromosome 19 (q13.1-13.3) and has a total of 7 exons and 6 introns [23]. Various

      

 

    


              
mellitus type 2 for over 10 years. Their result suggested that the  gene polymorphism
is associated with susceptibility to diabetic nephropathy [22]. Another similar study was
carried out in patients with type 1 diabetes to see if it contributes to genetic predisposition
   
               
TT genotypes may be protective factors [3]. These results were in accordance with our
           
   
 gene polymorphism with diabetic nephropathy. Their results suggested that 
gene polymorphism is not associated with the progression of diabetic nephropathy [25]. A

Table 3.

Ȁ

Ȁ

ȋαͷͻȌ

ȋαͷʹȌ

ȋαͷͺȌ
χʹ
Ǥ

Ǥ


Ǥ


ͳ
ȋͻͷΨȌ
ȋͻͷΨȌ
ȋͻͷΨȌ
ͷͳͺ͸

ͳʹȋʹͲǤ͵Ȍ
͵ʹȋͷͻǤʹȌ
͵ͺȋ͹͵ǤͳȌ
δͲǤͲͲͳ

ȋͳͳ͸͸Ȍ

͵͹ȋ͸ʹǤ͹Ȍ
ʹͲȋ͵͹ǤͲȌ
ͳʹȋʹ͵ǤͲ͸
Ȍ
ͻǤ͹͸ȋ͵ǤͺͻǦ
ʹͶǤͶͺȌ
δͲǤͲͲͲͳ
ͳǤͻ͹ȋͲǤͺͶǦͶǤ͸͸Ȍ
ͲǤͳͳͺʹ
ͶǤͻ͵ȋʹǤͲͻǦ
ͳͳǤ͸͵Ȍ
ͲǤͲͲͲ͵

ͳͲȋͳ͸ǤͻȌ
Ͳʹȋ͵Ǥ͹ͲȌ
Ͳʹȋ͵ǤͺͶȌ
ͳͷǤͺ͵ȋ͵ǤͲ͵Ǧ
ͺʹǤͷȌ
ͲǤͲͲͳͲ
ͳǤͳͺȋͲǤͳͷǦͺǤͻͳȌ
ͲǤͺ͸͹͵
ͳ͵Ǥ͵͵ȋʹǤͷͶǦ
͸ͻǤͻͲȌ
ͲǤͲͲʹʹ

ͲǤͳͶͷ͵
ͲǤͺͶͶ
ͲǤ͹͵ͻ

͸ͳȋͷͳǤ͸Ȍ
ͺͶȋ͹͹Ǥ͹Ȍ
ͺͺ
ȋͺͶǤ͸ʹȌ
δͲǤͲͲͳ


ͷ͹ȋͶͺǤ͵Ȍ
ʹͶȋʹʹǤ͵Ȍ
ͳ͸
ȋͳͷǤ͵ͺȌ
ͷǤͳ͵ȋʹǤ͹ͲǦ
ͻǤ͹ͺȌ
δͲǤͲͲͲͳ
ͳǤͷ͹ȋͲǤ͹ͺǦ͵Ǥͳ͸Ȍ
ͲǤʹͲͷͷ
͵Ǥʹ͹ȋͳǤͺ͵ǦͷǤͺͶȌ
ͲǤͲͲͲͳ
Ǧβ1
ͳͺͲͲͶ͹Ͳ

ͳͶ
ȋʹ͵Ǥ͹ʹȌ
ʹͷȋͶ͸Ǥ͵Ȍ
͵Ͳ
ȋͷ͹Ǥ͹ͲȌ
ͲǤͲͲͶ

ȋͺ͸ͻȌ

͵Ͳ
ȋͷͲǤͺͷȌ
ʹͳȋ͵ͺǤͻȌ
ͳͺȋ͵ͶǤ͸Ȍ
͵Ǥͷ͹ȋͳǤͷͲǦ
ͺǤͶ͸Ȍ
ͲǤͲͲ͵ͺ
ͳǤͷͶȋͲǤ͸͹͵ǤͷʹȌ
ͲǤʹͻͺ͵
ʹǤͷͷȋͳǤͲ͹Ǧ
͸ǤͲʹȌ
ͲǤͲ͵ʹͺ

ͳͷ
ȋʹͷǤͶ͵Ȍ
ͲͺȋͳͶǤͺȌ
ͲͶȋ͹Ǥ͹ͲȌ
͹ǤͲȋͳǤͻ͸Ǧ
ʹͶǤͻͺȌ
ͲǤͲͲʹ͹
͵ǤͶͺȋͲǤ͵Ͷ͵ͷǤʹʹȌ
ͲǤʹͻͲ͵
͵Ǥ͵ͶȋͳǤͳ͵Ǧ
ͻǤͺͷȌ
ͲǤͲʹͺʹ

ͲǤͻͻͳ
ͲǤ͸Ͳ͵
ͲǤͺͷ͹

ͷͺ
ȋͶͻǤͳͷȌ
͹ͳ
ȋ͸ͷǤ͹ͷȌ
͹ͺȋ͹ͷȌ
δͲǤͲͲͳ


͸Ͳ
ȋͷͲǤͺͷȌ
͵͹
ȋ͵ͶǤʹͷȌ
ʹ͸ȋʹͷȌ
͵ǤͳͲȋͳǤ͹ͷǦ
ͷǤͶͻȌ
ͲǤͲͲͲͳ
ͳǤͷ͸ȋͲǤͺ͸ʹǤͺ͵Ȍ
ͲǤͳͶͳͷ
ͳǤͻͺȋͳǤͳ͸Ǧ
͵Ǥ͵ͻȌ
ͲǤͲͳʹ͵
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 209
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
   
            

 gene is
           

            


      gene polymorphism with susceptibility to




 
to patients with AA genotype [27]. Another study conducted and observed the association
of the 

 
 genotypes between the patients and the
  
 
    
       

 gene polymorphism

Conclusion
In conclusion, our research suggested an association of allelic and genotypic frequencies
         
        

while using modern sequencing technologies.
Acknowledgements
 


There is no funding received to conduct the study, the authors contributed for the study







study.
Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 210
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy



All the authors have read and approved the article for publication

All the necessary data are included in manuscript, related data will be provided on
request from corresponding author
Disclosure Statement
The authors declared no competing interests
References
 
2005;365:1333–1346.
 


 


 

 

2016;45:761–767.
 

 
polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabet Med.
2005;22(1):69–73.
 


 

 

 
transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production,

 

 

 
contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

Cell Physiol Biochem 2024;58:203-211
DOI: 10.33594/000000702
Published online: 6 May 2024 211
Cellular Physiology
and Biochemistry
Cellular Physiology
and Biochemistry © 2024 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG
Ihsan et al.: Genetic Polymorphisms in Diabetic Nephropathy
 


 

2010;37:152–157.
 

 

 


 
 

 


 

2004;13:1649–1656.
 

 


 


 


 󰨠

 

 

... У кількох попередніх дослідженнях вивчалась роль поліморфізму гена AT1R в етіології діабетичної хвороби нирок, проте вони показали суперечливі результати [10,11,12,13]. Непослідовні висновки в роботах пояснюються генетичним різноманіттям і етнічною приналежністю різних груп населення. ...
Article
Full-text available
Мета роботи. виявити можливий зв’язок між поліморфізмом A1166C (rs 5186) гена рецептора ангіотензину II типу 1 (AT1R) і показниками функціонального стану нирок у хворих на цукровий діабет 2 типу з нефропатією. Методи. Обстежено 194 хворих на ДН: 108 жінок та 86 чоловіків. Вік хворих коливався від 43 до 80 років та становив в середньому (56,32±3,21) роки. Контрольну групу склали 48 здорових осіб. Дезоксирибонуклеїнові кислоти виділяли з крові стандартним методом з використанням набору реагентів «NeoPrep50» («Неоген», Україна) згідно інструкції виробника. Генотипування поліморфізму A1166C (rs 5186) гена AT1R проводили за технологією TaqMan із застосуванням набору Taq-Man® Fast Universal PCR Master Mix та TaqMan® SNP Assay. Статистичний аналіз генетичних асоціацій проводився з використанням програми SNP Stats. Результати. Аналіз даних за SNPStats продемонстрував вірогідну різницю у частоті зустрічальності генотипів та алелей досліджуваного поліморфізму в групі хворих з ДН в порівнянні з контролем, що відповідає: кодомінантній моделі успадкування ВШ 0,31 (0,12-0,81); р=0,044; домінантній моделі успадкування 0,36 (0,15-0,89); р=0,024; над-домінантній моделі успадкування 0,32 (0,12-0,80); р=0,012. Встановлено, що у хворих на ДН - носіїв C/C генотипу поліморфізму rs 5186 гена AT1R, мали місце достовірно вищі показники креатиніну 130,60 [46,44-214,76] мг/л, сечовини - 12,44 [2,55-27,43] мг/л, також нижчу ШКФ - 54,20 [25,19-83,21] мл/хв/1,73м2, порівняно з гетерозиготами A/C та гомозиготами C/C. Доведено, що хворі на ДН, гомозиготні за алелем С гена AT1R, мають достовірно вищі рівні альбуміну сечі (110,35 [12,81-233,50] мкг/мл), порівняно з гетерозиготами А/С (49,99 [22,41-77,58] мкг/мл). Найвищій рівень співвідношення альбумін/креатинін сечі у хворих на ДН було визначено у гомозигот С алелі гена AT1R (0,59 [0,08-1,10]), порівняно з гетерозиготами А/С (0,44 [0,16-0,72]), р<0,05 та гомозиготами А/А (0,27 [0,19-0,35]), р<0,05. Висновки. Хворі на ДН, гомозиготні за алелем С гена AT1R, мають достовірно вищі показники креатиніну, сечовини, рівні альбуміну сечі та співвідношення альбумін/креатинін сечі, а також нижчу ШКФ порівняно з гетерозиготами А/С та гомозиготами А/А. Ймовірно, наявність в генотипі С алелі може вважатися несприятливим фактором щодо погіршення фільтраційної функції нирок у пацієнтів з ЦД2 типу.
Article
Full-text available
Genetic polymorphisms of the angiotensin II type I receptor (AGTR1), has been reported to be the most probable candidate genes for hypertension, diabetes and complication of diabetes. Ethnic differences in the frequencies of these gene genotypes have also been reported. As there is no data available for AGTR1 polymorphism and T2DM in the Bengali population, it's our attempt to fill the scientific gap. To investigate whether the angiotensin II type I receptor gene A1166C (rs5186) polymorphism is associated with a risk of type 2 diabetes and nephropathy in Indian Bengali patients, in a case-control study, the AGTR1 gene (rs5186; A1166C) was examined in type 2 diabetic patients with and without nephropathy (T2DM: N=246; T2DNH: N= 168) and normal control (N=304) participants and genotyped using PCR-RFLP methods. Result of Fisher exact test for allelic association of SNP rs5186 exhibits significant difference in the allele frequencies between the control and T2DM groups (p= 0.0308). It is observed through the 4 genotypic model tests that additive model predicted significant association than basic genotype, dominant and recessive models and shows significant difference between CON vs. T2DM groups (p = 0.038). The present study reveals that the A1166C polymorphism (rs5186) of AGTR1 has a positive association with T2DM. This polymorphism with C allele may contribute to diabetic complication, nephropathy development particularly in T2DM patients.
Article
Full-text available
Background Hepcidin and hemochromatosis (HFE ) are iron regulatory proteins that are encoded by HAMP and HFE genes. Mutation in either HAMP gene or HFE gene causes Hepcidin protein deficiency that can lead to iron overload in beta thalassemia patients. The aim of this research work was to study the presence of G71D mutation of HAMP gene and H63D mutation of HFE gene in beta thalassemia major and minor group to check the association of these mutations with serum ferritin level of beta thalassemia patients. Methods The study was conducted on 42 beta thalassemia major and 20 beta thalassemia minor samples along with 20 control samples. The genotyping of both mutations has done by ARM‐PCR technique with specific set of primers. Results Significant effect of G71D and H63D mutations was observed on serum ferritin level of thalassemia major group. The risk allele of HAMP G71D and HFE H63D was found with high frequency (48% and 49%, respectively) in beta thalassemia major than in control group. High genotypic frequency of HAMP and HFE gene mutation gene mutation was observed in beta thalassemia major than beta thalassemia minor and control group (7% and 9%, respectively). Conclusion It can be concluded that both HAMP and HFE gene mutations show high frequency in beta thalassemia major patients and mean significant association between mutations and high serum ferritin level of beta thalassemia major patients but the nonsignificant results of Odd ratios showed that both mutations do not act as major risk factor in beta thalassemia major.
Article
Full-text available
Abstract Hepatocellular carcinoma is a primary liver malignancy in which the risk of development is always multifunctional. Interleukin-6 is a proinflammatory and multifunctional cytokine, which plays an important role in the immune response, haematopoiesis and defence against viral infection. We aimed to evaluate the frequency of Interleukin-6 mutations (rs2069837 and rs17147230) associated with genetic risk of hepatocellular carcinoma in Khyber Pakthunkhwa population. A total of 72 hepatocellular carcinoma cases and 38 controls were included in this study. The genomic DNA was extracted from the peripheral blood cells and Interleukin-6 genotyping was performed using T-ARMS-PCR technique. Our results show a significant increase risk of developing hepatocellular carcinoma with the mutation within Interleukin-6 gene with heterozygous G allele (rs2069837) (OR = 10.667, 95%CI = 3.923–29.001, p
Article
Full-text available
Background: Diabetes mellitus (DM) poses a severe threat to global public health. Diabetic nephropathy (DN) is one of the most common complications of diabetes and the leading cause of end-stage renal disease (ESRD). Approximately 30-40% of DM patients in the world progress to ESRD, which emphasizes the effect of genetic factors on DN. Family clustering also supports the important role of hereditary factors in DN and ESRD. Therefore, a large number of genetic studies have been carried out to identify susceptibility genes in different diabetic cohorts. Extensive susceptibility genes of DN and ESRD have not been identified until recently. Summary and key messages: Some of these associated genes function as pivotal regulators in the pathogenesis of DN, such as those related to glycometabolism and lipid metabolism. However, the functions of most of these genes remain unclear. In this article, we review several susceptibility genes according to their genetic functions to make it easier to determine their exact effect on DN and to provide a better understanding of the advancements from genetic studies. However, several challenges associated with investigating the genetic factors of DN still exist. For instance, it is difficult to determine whether these variants affect the expression of the protein they encode or other cytokines. More efforts should be made to determine how these genes influence the progression of DN. In addition, many results could not be replicated among races, suggesting that the association between genetic polymorphisms and DN is race-specific. Therefore, large, well-designed studies involving more relevant variables and ethnic groups and more relevant functional studies are urgently needed. These studies may be beneficial and retard the progression of DN by early intervention, especially for patients who carry certain risk alleles or genotypes.
Article
Full-text available
Background Diabetic nephropathy (DN) is one of the leading causes of death in patients with type 2 diabetes mellitus (T2DM). Several genome-wide association studies have introduced Engulfment and Cell Motility 1 (ELMO1) as a candidate gene which is associated with DN. This study assessed the association of ELMO1 gene polymorphisms with DN in order to investigate the effects of ELMO1 gene on susceptibility to DN in an Iranian population. Methods In the present study, 100 patients with T2DM, 100 patients with DN and 100 healthy subjects who were matched for sex were selected. Allele and genotype frequencies were determined by Tetra-ARMS PCR technique. In all groups, levels of FBS, creatinine, urea, HbA1C, urine levels of albumin creatinine ratio and glomerular filtration rate were measured. ResultsA statistically significant association was shown between G allele of rs741301 (odds ratio (OR) = 1.7 [95 % CI 1.17–2.63]; p value = 0.005), and GG genotypes of rs741301 (OR = 2.5 [95 % CI 1.2–5.4]; p value = 0.01) and DN. A significant association was not detected between allelic and genotypic frequencies of rs1345365 and DN. Linkage Disequilibrium (LD) between two variants was weak (D' = 0.11, r2 = 0.008). rs1345365A/rs741301A haplotypes were more frequent in patients with T2DM as compared to DN (OR = 0.5 [95 % CI 0.3–0.7]; p value = 0.0006). Also, genotypes of variant rs741301 in all subjects had significant difference with respect to the mean of ACR (p Value < 0.05). Conclusion This study first investigated the association of ELMO1 gene polymorphisms (rs741301) with DN in an Iranian population, supporting its key role as a candidate gene in the susceptibility to DN.
Article
Full-text available
Background: Transforming growth factor-beta 1(TGF-β1) T869C (rs1800470, the same below) gene polymorphism is notably relative with the development of Diabetic Nephropathy (DN), and CC/CT genotype diabetic have higher frequency of than TT genotype diabetic. To find out individual risk factors in the two genotypes especially in susceptible genotype could provide more efficient and targeted prevention. Methods: This was a prospective cohort study. A total of 251 type 2 diabetes mellitus (T2DM) patients [53.4% male, 56(52–67) years] were enrolled in this cohort study. Multiple concerned factors were collected and the relationship of these risk factors and development of DN were evaluated by Cox regression analysis. Hazard ratios of development of DN were calculated by Kaplan-Meier curves and the Cox proportional hazards model for CC/CT genotype versus TT genotype patients. Results: TGF-β1 T869C gene polymorphism was an independent predictor of DN in T2DM patients (HR, 2.08; 95%CI, 1.18–3.66; P=0.012). Hyperlipemia (HR, 1.91; 95%CI, 1.19–3.08; P=0.007), age (HR, 0.95; 95%CI, 0.93–0.98; P=0.001) and smoking status (HR, 2.36; 95%CI, 1.07–5.21; P=0.033) were risk indictors of the development of DN in CC/CT genotype patients. HbA1c (HR, 2.8; 95%CI, 1.07–7.30; P=0.036), hypertension (HR, 7.46; 95%CI, 1.38–40.29; P=0.02), and hyperlipemia (HR, 12.33; 95%CI, 1.05–145.39; P=0.046) were risk indictors for the development of DN in TT genotype patients. Conclusion: TGF-β1 T869C gene polymorphism was an independent predictor of DN for T2DM patients and CC/CT genotype had higher susceptibility to DN. CC/CT genotype and TT genotype patients had different risk indictors of DN.
Article
Transforming growth factor β1 (TGFβ1) is established to be involved in the pathogenesis of diabetic nephropathy. The diabetic milieu enhances oxidative stress and induces the expression of TGFβ1. TGFβ1 promotes cell hypertrophy and extracellular matrix accumulation in the mesangium, which decreases glomerular filtration rate and leads to chronic renal failure. Recently, TGFβ1 has been demonstrated to regulate urinary albumin excretion by both increasing glomerular permeability and decreasing reabsorption in the proximal tubules. TGFβ1 also increases urinary excretion of water, electrolytes and glucose by suppressing tubular reabsorption in both normal and diabetic conditions. Although TGFβ1 exerts hypertrophic and fibrogenic effects in diabetic nephropathy, whether suppression of the function of TGFβ1 can be an option to prevent or treat the complication is still controversial. This is partly because adrenal production of mineralocorticoids could be augmented by the suppression of TGFβ1. However, differentiating the molecular mechanisms for glomerulosclerosis from those for the suppression of the effects of mineralocorticoids by TGFβ1 may assist to develop novel therapeutic strategies for diabetic nephropathy. In this review we discuss recent findings on the role of TGFβ1 in diabetic nephropathy.
Article
1. Renal tubular epithelial cells can undergo epithelial to mesenchymal transition (EMT) under hyperglycaemic conditions, which is associated with renal interstitial fibrosis. Activation of the renin–angiotensin system (RAS) is involved in diabetic nephropathy. The present study investigated the positive role of angiotensin AT1 receptors in high glucose-induced EMT in cultured tubular epithelial cells. 2. A rat kidney proximal tubular epithelial cell line (NRK-52E) was used in the present study. Levels of EMT makers, namely E-cadherin and vimentin, were estimated using fluorescence immunocytochemistry, mRNA levels of angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and AT1 receptors were determined by real-time polymerase chain reaction, protein levels of E-cadherin, vimentin, fibronectin, matrix metallopeptidase (MMP)-9 and phosphorylated extracellular signal-regulated kinase (ERK) 1/2 were analysed by western blotting and the concentrations of angiotensin (Ang) II and transforming growth factor (TGF)-β1 in the culture medium were determined by enzyme immunoassay and ELISA. 3. High glucose (30 mmol/L) induced EMT and increased the synthesis of fibronectin and MMP-9. Furthermore, high glucose increased AGT, ACE and AT1 receptor mRNA levels, as well as AngII and TGF-β1 concentrations in the culture medium and ERK1/2 phosphorylation. Pretreatment of cells for 15 min with the AT1 receptor antagonist losartan (10−5 mol/L) attenuated high glucose-induced increases in TGF-β1 and ERK1/2 phosphorylation and reduced EMT, as well as the consequent synthesis of fibronectin and MMP-9. 4. The results of the present study suggest that the activated local RAS mediates high glucose-induced EMT. By activating AT1 receptors and stimulating TGF-β1 synthesis, the elevated local RAS participates in high glucose-induced EMT and increased extracellular matrix secretion.
Article
Abstract The association between angiotensinogen (AGT) M235T gene polymorphism and IgA nephropathy (IgAN) risk remains elusive. Our aim was to evaluate the association between AGT M235T gene polymorphism and IgAN susceptibility by performing a meta-analysis. Eligible studies were searched according to predefined criteria using electronic databases. Eight studies were identified for the analysis of the association between AGT M235T gene polymorphism and IgAN risk. M allele/MM genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.448 and 0.861, Caucasians: p = 0.618 and 0.886, Asians: p = 0.566 and 0.652). TT/MT genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.703 and 0.454, Caucasians: p = 0.975 and 0.946, Asians: p = 0.697 and 0.353). No evidence of publication bias was observed. In conclusion, AGT M235T gene polymorphism may not be correlated with IgAN susceptibility in overall populations, Caucasians and Asians. However, more studies should be performed in the future.